Physician profile
Jeffery A Johnson
NPI 1134181647
$1,723.71
in general payments reported to CMS, 2019-2025
12 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Pediatric Nephrology provider received nationally (typical 2025 total: $131).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.00 · 2020: $174 · 2021: $239 · 2022: $345 · 2023: $342 · 2024: $349 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.76 |
| Education | $238.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $496.76 | 2020-2024 | Aquadex Smartflow Console |
| Alexion Pharmaceuticals, INC. | $235.10 | 2021-2022 | |
| Kyowa Kirin, INC. | $218.38 | 2023-2024 | Crysvita |
| La Jolla Pharmaceutical Company | $128.60 | 2023 | Giapreza |
| Calliditas Therapeutics US INC. | $124.70 | 2025 | Tarpeyo |
| Rhythm Pharmaceuticals, INC. | $124.60 | 2022 | |
| Apellis Pharmaceuticals, INC. | $120.06 | 2025 | Empaveli |
| Aurinia Pharma U.S., INC. | $117.77 | 2021 | |
| Alnylam Pharmaceuticals INC. | $106.84 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $30.00 | 2019 | |
| Ambu INC. | $20.90 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.